When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

Crossref, an open registry of unique identifiers for scholarly metadata, has acquired the Retraction Watch database, which houses records of more than 42,000 retractions. The Retraction Watch Database ...

The Center for Scientific Integrity, the organisation behind the Retraction Watch blog and database, and Crossref, the global infrastructure underpinning research communications, both not-for-profits, ...

Launched in 2010 by American science journalists Adam Marcus and Ivan Oransky, the Retraction Watch website has become a valuable source of information on cases of scientific misconduct from around ...

Harvard researchers are far from immune to retractions, according to new data published online last month. In October, Retraction Watch — a blog “tracking retractions as a window into the scientific ...

Crossref, a nonprofit organization created by academic publishers to generate digital object identifiers (DOIs) for scientific articles and documents, has purchased Retraction Watch’s database, which ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Retractions are a sign that science is working as it should. But ...

On Thursday (October 25), the blog Retraction Watch, which tracks problematic scientific literature, released an online database of more than 18,000 papers and conference materials that have been ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Misconduct has contributed largely to a rising trend of ...

The Retraction Watch team claims to already catalog two-thirds of retractions as they occur; “we’ll need more resources to be comprehensive.” According to Bio-IT World, Retraction Watch “has been a ...

Emergency use authorisation, pharmaceutical companies announcing the results of clinical trials first through press releases, free access to all COVID-19 scientific papers published in journals and a ...